Therapeutic Solutions International Enters
into Multi-Million Dollar Master
Sales Agreement with Tiva Bio
Company Started by NFL
Chargers Hall of Famer Wes Chandler Collaborates with
TSOI to Provide Nutraceutical Approach to Chronic Traumatic
Encephalopathy
OCEANSIDE, CA --
December 12, 2019 -- InvestorsHub NewsWire
-- Therapeutics
Solutions International, Inc., (OTC
Markets:
TSOI)
announces today the
signing
of a Master Sales
Agreement with Tiva Bio to distribute the
nutraceutical line of products developed by TSOI.
Products to be
included in the Master Sales Agreement currently consists of
NanoStilbene,
NeuroStilbene, NanoPSA, Nano Plus, Nano Cannabidiol, and
ProJuvenol.
Future products will be added to the Master List as
commercialized.
"After more than a
year of discussions, collaborations, and demonstrating the
potent
properties of our
products
with Wes
Chandler and his Team, we are very excited to
execute this sales
agreement with our
great
friends
at Tiva Bio, a Wes Chandler Company, focused on
biotechnology,
their
mission
is to discover, develop, and bring to market novel
products
that are
designed to provide relief to an array of symptoms including
CTE,
pain,
nausea, anxiety, and inflammation," said Timothy Dixon,
President, and CEO of TSOI. "The Team Wes
has
assembled
in areas of science, marketing, and branding is second to
none. We are fortunate to work with such a well-fitted and
synergistic partner. This agreement only
marks the beginning of a long and beneficial relationship focused
on providing preventative and treatment approaches to chronic
traumatic encephalopathy."
About
Therapeutic Solutions International, Inc.
Therapeutic Solutions
International is focused on immune modulation for the treatment of
several specific diseases. Immune modulation refers to the ability
to upregulate (make more active) or downregulate (make less active)
one's immune system. The Company's corporate website is at
www.therapeuticsolutionsint.com
and our
e-commerce is at www.youcanordernow.com and for additional
info on NanoStilbene visit www.mynanostilbene.com.
About
Tiva Bio
Tiva Bio
is a biotechnology company dedicated to the development of
science-based products. We bring scientific
expertise to product formulation and dosing of plant-based
therapeutics to improve customers' quality of life, health, and
well-being.
These statements have
not been evaluated by the Food and Drug Administration. These
products are not intended to diagnose, treat, cure, or prevent any
disease.
Safe
Harbor
Statement
This
release contains forward-looking statements that are based upon
current expectations or beliefs, as well as a number of assumptions
about future events. Although we believe that the expectations
reflected in the
forward-looking statements and the assumptions upon which they are
based are reasonable, we can give no assurance that such
expectations and assumptions will prove to have been correct.
Forward-looking statements are generally identifiable by the use of
words like "may," "will," "should," "could," "expect,"
"anticipate," "estimate," "believe," "intend," or "project" or the
negative of these words or other variations on these words or
comparable terminology. The reader is cautioned not to put undue
reliance on these forward-looking statements, as these statements
are subject to numerous risk factors as set forth in our SEC
filings. To the extent that statements in this press release are
not strictly historical, including statements as to product launch
timing, revenue projections, business strategy, outlook,
objectives, future milestones, plans, intentions, goals, future
collaboration agreements, or otherwise as to future events, such
statements are forward-looking, and are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. The forward-looking statements contained in this release
are subject to certain risks and uncertainties that could cause
actual results to differ materially from the statements
made.
Contact
Information: